USPTO Rules Will Set Back Antibiotic Drug Development

Law360, New York (May 23, 2014, 5:16 PM EDT) -- There is an urgent need for novel antibiotics to treat bacterial pathogens that have become resistant to one or more commercially available antibiotics. In its recently released report "Antibiotic Resistance Threats in the United States, 2013," the Centers for Disease Control and Prevention conservatively estimates that over 2 million illnesses and 23,000 deaths are caused by antibiotic resistant bacteria every year....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!